Head Mounted Display by Integration of Phase-Conjugate Material

This invention has incorporated projective optics and phase conjugate material thus eliminating the requisite use of an external phase conjugate material to provide a see-through head mounted projective display. A key component of the invention is the use of optical imaging technology in combination with projective optics to make this revolutionary technology work. In previous head mounted projective displays the phase conjugate material had to be placed in the environment to display images, but in this invention one is not limited to the use of an external phase conjugate material but further extends its use to outdoor see-through augmented reality to produce images using the see-through head mounted projective display system. Furthermore, this invention extends the use of projective head mounted displays to clinical guided surgery, surgery medical, an outdoor augmented see-through virtual environment for military training and wearable computers

Head-mounted Display by Integration of Phase-Conjugate Material

This invention has incorporated projective optics and phase conjugate material thus eliminating the requisite use of an external phase conjugate material to provide a see-through head mounted projective display. A key component of the invention is the use of optical imaging technology in combination with projective optics to make this revolutionary technology work. In previous head mounted projective displays the phase conjugate material had to be placed in the environment to display images, but in this invention one is not limited to the use of an external phase conjugate material but further extends its use to outdoor see-through augmented reality to produce images using the see-through head mounted projective display system. Furthermore, this invention extends the use of projective head mounted displays to clinical guided surgery, surgery medical, an outdoor augmented see-through virtual environment for military training and wearable computers

Distributional and classical solutions to the Cauchy Boltzmann problem for soft potentials with integrable angular cross section

This paper focuses on the study of existence and uniqueness of distributional and classical solutions to the Cauchy Boltzmann problem for the soft potential case assuming $S^{n-1}$ integrability of the angular part of the collision kernel (Grad cut-off assumption). For this purpose we revisit the Kaniel--Shinbrot iteration technique to present an elementary proof of existence and uniqueness results that includes large data near a local Maxwellian regime with possibly infinite initial mass. We study the propagation of regularity using a recent estimate for the positive collision operator given in [3], by E. Carneiro and the authors, that permits to study such propagation without additional conditions on the collision kernel. Finally, an $L^{p}$-stability result (with $1\leq p\leq\infty$) is presented assuming the aforementioned condition.Comment: 19 page

In plane quantification of in vivo muscle elastic anisotropy factor by steered ultrasound pushing beams

Skeletal muscles are organized into distinct layers and exhibit anisotropic characteristics across various scales. Assessing the arrangement of skeletal muscles may provide valuable biomarkers for diagnosing muscle related pathologies and evaluating the efficacy of clinical interventions. In this study, we propose a novel ultrafast ultrasound sequence constituted of steered pushing beams was proposed for ultrasound elastography applications in transverse isotropic muscle. Based on the propagation of the shear wave vertical mode, it is possible to fit the experimental results to retrieve in the same imaging plane, the shear modulus parallel to fibers as well as the elastic anisotropy factor. The technique was demonstrated in vitro in phantoms and ex vivo in fusiform beef muscles. At last, the technique was applied in vivo on fusiform muscles (biceps braachi) and mono-penate muscles (gastrocnemius medialis) during stretching and contraction. This novel sequence provides access to new structural and mechanical biomarkers of muscle tissue, including the elastic anisotropy factor, within the same imaging plane. Additionally, it enables the investigation of multiples parameters during muscle active and passive length changes

D1.1 Analysis Report on Federated Infrastructure and Application Profile

Kawese, R., Fisichella, M., Deng, F., Friedrich, M., Niemann, K., Börner, D., Holtkamp, P., Hun-Ha, K., Maxwell, K., Parodi, E., Pawlowski, J., Pirkkalainen, H., Rodrigo, C., & Schwertel, U. (2010). D1.1 Analysis Report on Federated Infrastructure and Application Profile. OpenScout project deliverable.The present deliverable aims to report on functionalities of the first step of the described process. In other words, the deliverable describes how the consortium will gather the learning objects metadata, centralize the access to existing learning resources and form a suitable application profile which will contribute to a proper and suitable modeling, retrieval and presentation of the required information (regarding the learning objects) to the interested users. The described approach is the foundation for the federated, skill-based search and learning object retrieval. The deliverable focuses on reporting the analysis of the available repositories and the best infrastructure that can support OpenScout’s initiative. The deliverable explains the motivations behind the chosen infrastructure based on the study of available information and previous research and literature.The work on this publication has been sponsored by the OpenScout (Skill based scouting of open user-generated and community-improved content for management education and training) Targeted Project that is funded by the European Commission’s 7th Framework Programme. Contract ECP-2008-EDU-42801

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

SummaryBackground The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden of disease. By providing national and subnational assessments spanning the past 25 years, this study can inform debates on the importance of addressing risks in context. Methods We used the comparative risk assessment framework developed for previous iterations of the Global Burden of Disease Study to estimate attributable deaths, disability-adjusted life-years (DALYs), and trends in exposure by age group, sex, year, and geography for 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks from 1990 to 2015. This study included 388 risk-outcome pairs that met World Cancer Research Fund-defined criteria for convincing or probable evidence. We extracted relative risk and exposure estimates from randomised controlled trials, cohorts, pooled cohorts, household surveys, census data, satellite data, and other sources. We used statistical models to pool data, adjust for bias, and incorporate covariates. We developed a metric that allows comparisons of exposure across risk factors—the summary exposure value. Using the counterfactual scenario of theoretical minimum risk level, we estimated the portion of deaths and DALYs that could be attributed to a given risk. We decomposed trends in attributable burden into contributions from population growth, population age structure, risk exposure, and risk-deleted cause-specific DALY rates. We characterised risk exposure in relation to a Socio-demographic Index (SDI). Findings Between 1990 and 2015, global exposure to unsafe sanitation, household air pollution, childhood underweight, childhood stunting, and smoking each decreased by more than 25%. Global exposure for several occupational risks, high body-mass index (BMI), and drug use increased by more than 25% over the same period. All risks jointly evaluated in 2015 accounted for 57·8% (95% CI 56·6–58·8) of global deaths and 41·2% (39·8–42·8) of DALYs. In 2015, the ten largest contributors to global DALYs among Level 3 risks were high systolic blood pressure (211·8 million [192·7 million to 231·1 million] global DALYs), smoking (148·6 million [134·2 million to 163·1 million]), high fasting plasma glucose (143·1 million [125·1 million to 163·5 million]), high BMI (120·1 million [83·8 million to 158·4 million]), childhood undernutrition (113·3 million [103·9 million to 123·4 million]), ambient particulate matter (103·1 million [90·8 million to 115·1 million]), high total cholesterol (88·7 million [74·6 million to 105·7 million]), household air pollution (85·6 million [66·7 million to 106·1 million]), alcohol use (85·0 million [77·2 million to 93·0 million]), and diets high in sodium (83·0 million [49·3 million to 127·5 million]). From 1990 to 2015, attributable DALYs declined for micronutrient deficiencies, childhood undernutrition, unsafe sanitation and water, and household air pollution; reductions in risk-deleted DALY rates rather than reductions in exposure drove these declines. Rising exposure contributed to notable increases in attributable DALYs from high BMI, high fasting plasma glucose, occupational carcinogens, and drug use. Environmental risks and childhood undernutrition declined steadily with SDI; low physical activity, high BMI, and high fasting plasma glucose increased with SDI. In 119 countries, metabolic risks, such as high BMI and fasting plasma glucose, contributed the most attributable DALYs in 2015. Regionally, smoking still ranked among the leading five risk factors for attributable DALYs in 109 countries; childhood underweight and unsafe sex remained primary drivers of early death and disability in much of sub-Saharan Africa. Interpretation Declines in some key environmental risks have contributed to declines in critical infectious diseases. Some risks appear to be invariant to SDI. Increasing risks, including high BMI, high fasting plasma glucose, drug use, and some occupational exposures, contribute to rising burden from some conditions, but also provide opportunities for intervention. Some highly preventable risks, such as smoking, remain major causes of attributable DALYs, even as exposure is declining. Public policy makers need to pay attention to the risks that are increasingly major contributors to global burden. Funding Bill & Melinda Gates Foundation

Standardizing Clinical Trials Workflow Representation in UML for International Site Comparison

BACKGROUND: With the globalization of clinical trials, a growing emphasis has been placed on the standardization of the workflow in order to ensure the reproducibility and reliability of the overall trial. Despite the importance of workflow evaluation, to our knowledge no previous studies have attempted to adapt existing modeling languages to standardize the representation of clinical trials. Unified Modeling Language (UML) is a computational language that can be used to model operational workflow, and a UML profile can be developed to standardize UML models within a given domain. This paper's objective is to develop a UML profile to extend the UML Activity Diagram schema into the clinical trials domain, defining a standard representation for clinical trial workflow diagrams in UML. METHODS: Two Brazilian clinical trial sites in rheumatology and oncology were examined to model their workflow and collect time-motion data. UML modeling was conducted in Eclipse, and a UML profile was developed to incorporate information used in discrete event simulation software. RESULTS: Ethnographic observation revealed bottlenecks in workflow: these included tasks requiring full commitment of CRCs, transferring notes from paper to computers, deviations from standard operating procedures, and conflicts between different IT systems. Time-motion analysis revealed that nurses' activities took up the most time in the workflow and contained a high frequency of shorter duration activities. Administrative assistants performed more activities near the beginning and end of the workflow. Overall, clinical trial tasks had a greater frequency than clinic routines or other general activities. CONCLUSIONS: This paper describes a method for modeling clinical trial workflow in UML and standardizing these workflow diagrams through a UML profile. In the increasingly global environment of clinical trials, the standardization of workflow modeling is a necessary precursor to conducting a comparative analysis of international clinical trials workflows